Holen Sie sich die Stockscreener-App
5.08
0.59%
-0.03
Handel nachbörslich:
5.12
0.04
+0.79%
Schlusskurs vom Vortag:
$5.11
Offen:
$5.17
24-Stunden-Volumen:
20,280
Relative Volume:
0.07
Marktkapitalisierung:
$42.37M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-11.46M
KGV:
-0.3629
EPS:
-14
Netto-Cashflow:
$-24.56M
1W Leistung:
+7.86%
1M Leistung:
-23.38%
6M Leistung:
+100.00%
1J Leistung:
+14.16%
1-Tages-Spanne:
$5.008
$5.25
1-Wochen-Bereich:
$4.56
$5.4799
52-Wochen-Spanne:
$1.20
$12.15
Evaxion A S Adr Stock (EVAX) Company Profile
Vergleichen Sie EVAX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EVAX
Evaxion A S Adr
|
5.08 | 42.62M | 0 | -11.46M | -24.56M | -14.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Evaxion A S Adr Stock (EVAX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-04-02 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2024-02-12 | Eingeleitet | H.C. Wainwright | Buy |
Evaxion A S Adr Aktie (EVAX) Neueste Nachrichten
European ADRs Edge Higher Despite Mixed Stock Moves - Finimize
Brokerages Set Evaxion A/S – Sponsored ADR (NASDAQ:EVAX) Target Price at $12.33 - Defense World
Evaxion Seeks New Partner For Gonorrhea Vaccine After Merck Opts Out - Sahm
Evaxion Seeks New Partner For Gonorrhea Vaccine After Merck Opts Out - Benzinga
European Firms Make Gains On US Markets As ADR Index Rises - Finimize
Evaxion Biotech Reports Strong Q3 2025 Results - MSN
Brokerages Set Evaxion A/S – Sponsored ADR (NASDAQ:EVAX) Price Target at $12.33 - Defense World
European ADRs Edge Up With Gains Led By Evaxion - Finimize
Evaxion Biotech’s Earnings Call Highlights Strategic Growth - TipRanks
Analysts Set Evaxion A/S – Sponsored ADR (NASDAQ:EVAX) PT at $12.33 - Defense World
European Biotech Stocks Outperformed As Broader Market Dipped - Finimize
European ADRs Barely Budge While Gainers And Losers Trade Places - Finimize
Evaxion A/S (NASDAQ:EVAX) Given Buy Rating at HC Wainwright - Defense World
European ADRs Edge Higher As Healthcare Leads Gains - Finimize
Take off with Evaxion A/S ADR (EVAX): Get ready for trading - setenews.com
Evaxion A/S – Sponsored ADR (NASDAQ:EVAX) Sees Large Growth in Short Interest - Defense World
Evaxion (NASDAQ:EVAX) Stock Rockets After AI-Powered Cancer Vaccine Breakthrough - ts2.tech
Nothing is Better Than Connexa Sports Technologies Inc (YYAI) stock at the moment - Setenews
Biotech Stocks Lead European ADRs Higher On Wall Street - Finimize
European Equities Traded in the US as American Depositary Fall Sharply in Tuesday Trading - MSN
Finanzdaten der Evaxion A S Adr-Aktie (EVAX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):